Product Information
CH5183284 is a monoclonal antibody that binds to the tyrosine kinase domain of the HER2 protein. It has been shown to inhibit angiogenesis in vitro, which may be due to its ability to block epidermal growth factor (EGF) signalling. This drug also inhibits EGF-induced migration of prostate cancer cells and skin cancer cells in vitro. CH5183284 has potential as a biomarker for tumours that overexpress HER2, as well as being a potential target for cancer therapy.
Chemical properties
Technical inquiry about: 3D-QAC22925 CH5183284
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.